News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,758 Results
Type
Article (87853)
Company Profile (743)
Press Release (780143)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (233222)
Career Advice (4144)
Deals (39883)
Drug Delivery (150)
Drug Development (91366)
Employer Resources (205)
FDA (18358)
Job Trends (17428)
News (397762)
Policy (39944)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (1)
Accelerated approval (34)
Adcomms (32)
Allergies (145)
Alliances (56969)
ALS (181)
Alzheimer's disease (1791)
Antibody-drug conjugate (ADC) (342)
Approvals (18560)
Artificial intelligence (582)
Autoimmune disease (164)
Automation (38)
Bankruptcy (404)
Best Places to Work (12617)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (458)
Bladder cancer (161)
Brain cancer (62)
Breast cancer (659)
Cancer (5000)
Cardiovascular disease (439)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (54)
Celiac Disease (2)
Cell therapy (813)
Cervical cancer (37)
Clinical research (76976)
Collaboration (1823)
Company closure (4)
Compensation (1173)
Complete response letters (69)
COVID-19 (2986)
CRISPR (99)
C-suite (868)
Cystic fibrosis (153)
Data (6318)
Decentralized trials (2)
Denatured (73)
Depression (144)
Diabetes (513)
Diagnostics (7219)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (275)
Drug pricing (211)
Drug shortages (32)
Duchenne muscular dystrophy (240)
Earnings (100065)
Editorial (63)
Employer branding (25)
Employer resources (173)
Events (134920)
Executive appointments (1005)
FDA (21527)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1536)
Gene editing (216)
Generative AI (52)
Gene therapy (668)
GLP-1 (1098)
Government (5422)
Grass and pollen (7)
Guidances (385)
Healthcare (20921)
HIV (58)
Huntington's disease (50)
IgA nephropathy (85)
Immunology and inflammation (287)
Immuno-oncology (63)
Indications (105)
Infectious disease (3260)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (117)
Intellectual property (249)
Interviews (816)
IPO (17954)
IRA (57)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (16)
Labor market (94)
Layoffs (653)
Leadership (39)
Legal (10147)
Liver cancer (98)
Longevity (15)
Lung cancer (674)
Lymphoma (382)
Machine learning (44)
Management (66)
Manufacturing (839)
MASH (174)
Medical device (14989)
Medtech (15041)
Mergers & acquisitions (22973)
Metabolic disorders (1366)
Multiple sclerosis (166)
NASH (23)
Neurodegenerative disease (352)
Neuropsychiatric disorders (97)
Neuroscience (3102)
Neurotech (1)
NextGen: Class of 2026 (7688)
Non-profit (5108)
Now hiring (66)
Obesity (657)
Opinion (333)
Ovarian cancer (169)
Pain (210)
Pancreatic cancer (232)
Parkinson's disease (293)
Partnered (37)
Patents (506)
Patient recruitment (493)
Peanut (60)
People (66851)
Pharmaceutical (135)
Pharmacy benefit managers (32)
Phase 1 (23793)
Phase 2 (33421)
Phase 3 (25167)
Pipeline (5229)
Policy (332)
Postmarket research (3553)
Preclinical (10681)
Press Release (72)
Prostate cancer (243)
Psychedelics (55)
Radiopharmaceuticals (299)
Rare diseases (913)
Real estate (7440)
Recruiting (80)
Regulatory (29005)
Reports (67)
Research institute (2721)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (78)
Schizophrenia (157)
Series A (260)
Series B (198)
Service/supplier (27)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4334)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (95)
The Weekly (122)
Vaccines (1128)
Venture capital (97)
Weight loss (443)
Women's health (92)
Worklife (22)
Date
Today (77)
Last 7 days (634)
Last 30 days (2128)
Last 365 days (31444)
2026 (3052)
2025 (31829)
2024 (37559)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1289)
Alabama (92)
Alaska (7)
Arizona (339)
Arkansas (14)
Asia (51541)
Australia (9054)
California (11545)
Canada (3310)
China (1170)
Colorado (489)
Connecticut (487)
Delaware (341)
Europe (118274)
Florida (1697)
Georgia (364)
Hawaii (4)
Idaho (68)
Illinois (928)
India (68)
Indiana (532)
Iowa (24)
Japan (431)
Kansas (133)
Kentucky (41)
Louisiana (29)
Maine (77)
Maryland (1445)
Massachusetts (8454)
Michigan (336)
Minnesota (652)
Mississippi (6)
Missouri (130)
Montana (34)
Nebraska (29)
Nevada (125)
New Hampshire (82)
New Jersey (3075)
New Mexico (32)
New York (3048)
North Carolina (1600)
North Dakota (10)
Northern California (5565)
Ohio (338)
Oklahoma (23)
Oregon (53)
Pennsylvania (2307)
Puerto Rico (23)
Rhode Island (49)
South America (1663)
South Carolina (65)
South Dakota (1)
Southern California (4450)
Tennessee (174)
Texas (1796)
United States (41355)
Utah (345)
Vermont (1)
Virginia (274)
Washington D.C. (85)
Washington State (968)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
868,758 Results for "tevogen bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
February 2, 2026
·
5 min read
Press Releases
Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure
August 28, 2025
·
4 min read
Press Releases
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
January 13, 2026
·
6 min read
Press Releases
Tevogen Bio Announces 2025 Annual Meeting
April 28, 2025
·
2 min read
Press Releases
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn
November 3, 2025
·
4 min read
Press Releases
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
October 30, 2025
·
5 min read
Pharm Country
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN
Tevogen Bio Holdings Inc. has announced the completion of Tevogen Bio Inc’s previously announced business combination with Semper Paratus Acquisition Corporation, leading to the formation of Tevogen Bio Holdings Inc.
February 14, 2024
·
7 min read
Press Releases
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
April 9, 2025
·
5 min read
Press Releases
Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest
October 16, 2025
·
4 min read
Business
Tevogen Bio Reports First Quarter 2024 Financial Results
Tevogen Bio Holdings Inc. has announced financial results for the fiscal quarter ended March 31, 2024, and filed its quarterly report on Form 10-Q with the Securities and Exchange Commission.
May 29, 2024
·
7 min read
1 of 86,876
Next
